14 Pertussis (whooping cough)

14.5 Recommended immunisation schedule

14.5.1 Children

A primary course of pertussis vaccine is given as DTaP-IPV-HepB/Hib (Infanrix-hexa) at ages 6 weeks, 3 months and 5 months, followed by a dose of DTaP-IPV (Infanrix-IPV) at age 4 years. A further booster is given at age 11 years (school year 7) as Tdap (Boostrix).

Dose intervals

The minimum interval between doses is four weeks, and the first dose should not be given before four weeks of age. If a course of immunisation is interrupted for any reason it may be resumed without repeating prior doses (see Appendix 2). A booster dose should be given no earlier than six months after the primary series.

Catch-up immunisation

See Appendix 2 for detailed catch-up immunisation information.

Dose interval between Td and Tdap

No minimum interval is required between Td and Tdap,58–60 unless Tdap is being given as part of a primary immunisation course.

14.5.2 PregnancyTop

Pregnant women should receive a dose of Tdap (funded) from 28 to 38 weeks’ gestation. This should be given during each pregnancy.61

​See section 4.1.2 for information about maternal pertussis vaccine effectiveness and safety. 

14.5.3 (Re-)vaccinationTop

Pertussis-containing vaccines are funded for (re-)vaccination of eligible patients, as follows.

DTaP-IPV-HepB/Hib (Infanrix-hexa; for children aged under 10 years), DTaP-IPV (Infanrix-IPV) and Tdap (Boostrix) are funded for patients: 

See also sections 4.2 and 4.3.

14.5.4 Recommended but not fundedTop

Tdap is recommended but not funded by the Ministry of Health for: